Senate Finance Committee Chair Wyden Issues Statement on PhRMA Lawsuit to Ban Medicare Prescription Drug Negotiation
June 22, 2023
June 22, 2023
WASHINGTON, June 22 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following statement on June 21, 2023:
* * *
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against provisions in the Inflation Reduction Act written to lower the cost of prescription drugs for seniors and taxpayers:
"It's no surprise that . . .
* * *
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against provisions in the Inflation Reduction Act written to lower the cost of prescription drugs for seniors and taxpayers:
"It's no surprise that . . .